4 March 2021

Ocugen and Bharat Biotech announced the former’s whole inactivated Covid-19 vaccine COVAXIN achieved 81% efficacy in its first interim analysis of the Phase II study. Analysis from the National Institute of Virology (NIV) indicate that the vaccine’s has the ability to protection against the UK and other variants.

Health Canada has approved a submission from Pfizer and BioNTech to allow their Covid-19 vaccine to be transported and stored at standard freezer temperatures, between -25°C and -15°C, instead of ultra-cold conditions for two weeks. This facilitates more flexible transportation, as well as local re-distribution of the vaccine.

The Russian Direct Investment Fund (RDIF)’s  Sputnik V Covid-19 has been approved by regulatory agencies in the Republic of Angola, the Congo and Djibouti. Sputnik V is now emergency approved in 42 countries worldwide.


How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.